1. Home
  2. ASPSW vs SCLXW Comparison

ASPSW vs SCLXW Comparison

Compare ASPSW & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Altisource Portfolio Solutions S.A.

ASPSW

Altisource Portfolio Solutions S.A.

N/A

Current Price

$0.38

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

N/A

Current Price

$0.09

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASPSW
SCLXW
Founded
N/A
N/A
Country
Luxembourg
United States
Employees
1160
30
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ASPSW
SCLXW
Price
$0.38
$0.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
26.7K
2.4K
Earning Date
N/A
03-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$55,152,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
22.02
52 Week Low
$0.25
$0.04
52 Week High
$1.28
$0.64

Technical Indicators

Market Signals
Indicator
ASPSW
SCLXW
Relative Strength Index (RSI) 49.85 37.12
Support Level $0.26 $0.06
Resistance Level $0.43 $0.12
Average True Range (ATR) 0.03 0.02
MACD -0.00 -0.00
Stochastic Oscillator 22.44 0.00

Price Performance

Historical Comparison
ASPSW
SCLXW

About ASPSW Altisource Portfolio Solutions S.A.

Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: